{
  "meta": {
    "id": "test4",
    "title": "Concepts",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 2-year-old child presents to the pediatric outpatient department with a week-long fever but otherwise normal physical examination findings. To rule out an inborn error of metabolism, a urine screening test is performed, yielding the following results: Benedict\u2019s test - positive Blood Glucose - 110 mg % Bial\u2019s test - positive Urine glucose, fructose and galactose - Negative. What is your most probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Essential pentosuria",
          "correct": true
        },
        {
          "label": "B",
          "text": "Essential fructosuria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hereditary fructose intolerance",
          "correct": false
        },
        {
          "label": "D",
          "text": "Galactosemia",
          "correct": false
        }
      ],
      "correct_answer": "A. Essential pentosuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Essential pentosuria is a benign, inherited condition caused by a deficiency of L-xylulose reductase , an enzyme of the glucuronic acid pathway . The defect leads to the accumulation and urinary excretion of L-xylulose , a pentose sugar.</li><li>\u2022 benign, inherited condition</li><li>\u2022 L-xylulose reductase</li><li>\u2022 glucuronic acid pathway</li><li>\u2022 L-xylulose</li><li>\u2022 Because L-xylulose is a reducing sugar , it reacts positively with Benedict\u2019s test , even when blood glucose is normal \u2014 which is exactly what the lab findings here show.</li><li>\u2022 L-xylulose is a reducing sugar</li><li>\u2022 Benedict\u2019s test</li><li>\u2022 blood glucose is normal</li><li>\u2022 Bial\u2019s test specifically detects pentoses and produces a characteristic blue-green color , confirming the presence of a pentose rather than a hexose (like glucose, fructose, or galactose).</li><li>\u2022 Bial\u2019s test</li><li>\u2022 pentoses</li><li>\u2022 blue-green color</li><li>\u2022 In this case:</li><li>\u2022 Benedict\u2019s test: Positive \u2192 Reducing sugar is present. Blood glucose: Normal (110 mg/dL) \u2192 rules out diabetes. Urine glucose, fructose, galactose: Negative \u2192 excludes common hexose sugars. Bial\u2019s test: Positive \u2192 confirms the sugar is a pentose.</li><li>\u2022 Benedict\u2019s test: Positive \u2192 Reducing sugar is present.</li><li>\u2022 Benedict\u2019s test: Positive</li><li>\u2022 Blood glucose: Normal (110 mg/dL) \u2192 rules out diabetes.</li><li>\u2022 Blood glucose: Normal (110 mg/dL)</li><li>\u2022 Urine glucose, fructose, galactose: Negative \u2192 excludes common hexose sugars.</li><li>\u2022 Urine glucose, fructose, galactose: Negative</li><li>\u2022 Bial\u2019s test: Positive \u2192 confirms the sugar is a pentose.</li><li>\u2022 Bial\u2019s test: Positive</li><li>\u2022 All this points clearly to essential pentosuria .</li><li>\u2022 essential pentosuria</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B \u2014 Essential Fructosuria: Fructose would be detected in urine (fructosuria), confirmed by a positive Seliwanoff\u2019s test (specific for ketohexoses like fructose). Here, fructose is absent, ruling this out. Option C \u2014 Hereditary Fructose Intolerance: This condition involves aldolase B deficiency , leading to trapped fructose-1-phosphate . Symptoms include hypoglycemia, vomiting, liver damage when fructose is ingested, and fructose would be present in urine, but here it's negative . Option D \u2014 Galactosemia: Characterized by defective metabolism of galactose, usually due to galactose-1-phosphate uridyl transferase deficiency . Galactose would be detectable in urine (but here, it\u2019s negative) and typically presents with cataracts, hepatomegaly.</li><li>\u2022 Option B \u2014 Essential Fructosuria: Fructose would be detected in urine (fructosuria), confirmed by a positive Seliwanoff\u2019s test (specific for ketohexoses like fructose). Here, fructose is absent, ruling this out.</li><li>\u2022 Option B \u2014 Essential Fructosuria:</li><li>\u2022 positive Seliwanoff\u2019s test</li><li>\u2022 Option C \u2014 Hereditary Fructose Intolerance: This condition involves aldolase B deficiency , leading to trapped fructose-1-phosphate . Symptoms include hypoglycemia, vomiting, liver damage when fructose is ingested, and fructose would be present in urine, but here it's negative .</li><li>\u2022 Option C \u2014 Hereditary Fructose Intolerance:</li><li>\u2022 aldolase B deficiency</li><li>\u2022 fructose-1-phosphate</li><li>\u2022 negative</li><li>\u2022 Option D \u2014 Galactosemia: Characterized by defective metabolism of galactose, usually due to galactose-1-phosphate uridyl transferase deficiency . Galactose would be detectable in urine (but here, it\u2019s negative) and typically presents with cataracts, hepatomegaly.</li><li>\u2022 Option D \u2014 Galactosemia:</li><li>\u2022 galactose-1-phosphate uridyl transferase deficiency</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Essential Pentosuria is a harmless, inherited metabolic condition characterized by the excretion of the pentose sugar L-xylulose in urine. This can lead to false-positive results on tests for reducing sugars (Benedict\u2019s) despite normal blood glucose levels. Bial\u2019s test further confirms the presence of pentoses, distinguishing it from hexoses like glucose, fructose, or galactose.</li><li>\u27a4 Essential Pentosuria</li><li>\u27a4 L-xylulose</li><li>\u27a4 Bial\u2019s test</li><li>\u27a4 Ref: Harper 30/e: p196, 205.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8d70e460",
      "audio": ""
    },
    {
      "text": "A 30-year-old female patient presents with the complaint of progressively darkened, velvety patches of skin on her neck and axillary regions. These skin changes have been accompanied by increased thirst and frequent urination. Given these symptoms and the characteristic skin findings, which of the following could be the underlying molecular mechanism of her condition?",
      "options": [
        {
          "label": "A",
          "text": "Dysfunctional glucagon receptors",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dysfunctional EGF receptors",
          "correct": false
        },
        {
          "label": "C",
          "text": "Persistently inhibited insulin receptors",
          "correct": true
        },
        {
          "label": "D",
          "text": "Persistently stimulated insulin receptors",
          "correct": false
        }
      ],
      "correct_answer": "C. Persistently inhibited insulin receptors",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture1_qOWv6QL.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Options A: Dysfunctional glucagon receptors typically would not result in skin changes like those described. Glucagon is a catabolic hormone that raises blood glucose levels.</li><li>\u2022 Options A:</li><li>\u2022 Dysfunctional glucagon receptors</li><li>\u2022 not result in skin changes</li><li>\u2022 Options B: Dysfunctional EGF receptors are associated with various cellular dysfunctions and cancer, not typically with the skin changes seen in acanthosis nigricans.</li><li>\u2022 Options B:</li><li>\u2022 Dysfunctional EGF receptors</li><li>\u2022 cellular dysfunctions</li><li>\u2022 cancer,</li><li>\u2022 Options D: Only inhibition leads to insulin resistance.</li><li>\u2022 Options D:</li><li>\u2022 inhibition leads</li><li>\u2022 insulin resistance.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Acanthosis nigrican\u2019s, is closely related to insulin resistance. The darkened skin patches are due to hyperinsulinemia that occurs secondary to insulin receptor inhibition, leading to increased insulin-like growth factor activity on skin cells.</li><li>\u27a4 Acanthosis nigrican\u2019s,</li><li>\u27a4 insulin resistance.</li><li>\u27a4 darkened skin patches</li><li>\u27a4 hyperinsulinemia</li><li>\u27a4 secondary to insulin receptor inhibition,</li><li>\u27a4 increased insulin-like growth factor</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 173,174,764 .</li><li>\u27a4 Ref :</li><li>\u27a4 DM Vasudevan 9/e: p 173,174,764</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f7988745",
      "audio": ""
    },
    {
      "text": "A 45-year-old male patient with a history of jaundice was subjected to a direct Van den Bergh reaction as part of his diagnostic workup. The test came positive. Based on these results, which type of bilirubin is present in the patient's blood serum that would cause a positive direct Van den Bergh\u2019s reaction?",
      "options": [
        {
          "label": "A",
          "text": "Conjugated bilirubin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Unconjugated bilirubin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Urobilinogen",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bile salts",
          "correct": false
        }
      ],
      "correct_answer": "A. Conjugated bilirubin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Conjugated bilirubin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Van den Bergh reaction</li><li>\u2022 conjugated (direct) bilirubin</li><li>\u2022 unconjugated (indirect) bilirubin</li><li>\u2022 Conjugated bilirubin is water-soluble because it has been conjugated with glucuronic acid in the liver. It reacts directly with diazotized sulfanilic acid (diazo reagent) to form a purple azo dye \u2014 without requiring alcohol. This immediate reaction is called a Direct Positive Van den Bergh Test .</li><li>\u2022 Conjugated bilirubin is water-soluble because it has been conjugated with glucuronic acid in the liver. It reacts directly with diazotized sulfanilic acid (diazo reagent) to form a purple azo dye \u2014 without requiring alcohol. This immediate reaction is called a Direct Positive Van den Bergh Test .</li><li>\u2022 Conjugated bilirubin</li><li>\u2022 water-soluble</li><li>\u2022 directly</li><li>\u2022 diazotized sulfanilic acid (diazo reagent)</li><li>\u2022 purple azo dye</li><li>\u2022 Direct Positive Van den Bergh Test</li><li>\u2022 So, a positive direct reaction means conjugated bilirubin is present.</li><li>\u2022 positive direct reaction</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B \u2014 Unconjugated (free) bilirubin: Incorrect. Unconjugated bilirubin is water-insoluble and does not react directly in an aqueous solution with the diazo reagent. It needs to be dissolved in alcohol first, and then the test becomes positive. This is called an indirect reaction . Option C \u2014 Urobilinogen: Incorrect. Urobilinogen is tested with Ehrlich\u2019s reagent (p-dimethylaminobenzaldehyde) , not the diazo reagent, and forms a red color . Option D \u2014 Bile salts: Incorrect. Bile salts are detected by Hay\u2019s sulfur test , which relies on surface tension reduction, not a colorimetric diazo reaction.</li><li>\u2022 Option B \u2014 Unconjugated (free) bilirubin: Incorrect. Unconjugated bilirubin is water-insoluble and does not react directly in an aqueous solution with the diazo reagent. It needs to be dissolved in alcohol first, and then the test becomes positive. This is called an indirect reaction .</li><li>\u2022 Option B \u2014 Unconjugated (free) bilirubin:</li><li>\u2022 water-insoluble</li><li>\u2022 not react directly</li><li>\u2022 alcohol</li><li>\u2022 indirect reaction</li><li>\u2022 Option C \u2014 Urobilinogen: Incorrect. Urobilinogen is tested with Ehrlich\u2019s reagent (p-dimethylaminobenzaldehyde) , not the diazo reagent, and forms a red color .</li><li>\u2022 Option C \u2014 Urobilinogen:</li><li>\u2022 Ehrlich\u2019s reagent (p-dimethylaminobenzaldehyde)</li><li>\u2022 red color</li><li>\u2022 Option D \u2014 Bile salts: Incorrect. Bile salts are detected by Hay\u2019s sulfur test , which relies on surface tension reduction, not a colorimetric diazo reaction.</li><li>\u2022 Option D \u2014 Bile salts:</li><li>\u2022 Hay\u2019s sulfur test</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A positive direct Van den Bergh reaction confirms the presence of conjugated (water-soluble) bilirubin in serum. Elevated conjugated bilirubin is typically seen in hepatocellular dysfunction, cholestasis, or bile duct obstruction \u2014 situations where conjugated bilirubin escapes into the bloodstream.</li><li>\u27a4 positive direct Van den Bergh reaction</li><li>\u27a4 conjugated (water-soluble) bilirubin</li><li>\u27a4 hepatocellular dysfunction, cholestasis, or bile duct obstruction</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 369, 370, 398, 399.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8b151666",
      "audio": ""
    },
    {
      "text": "In the outpatient department, three patients suspected of having dysglycemia underwent an oral glucose tolerance test (OGTT). Their plasma glucose levels were measured at intervals after glucose ingestion, as depicted in the graph. Based on their glucose level trends, which patient most likely represents a pre-diabetic state?",
      "options": [
        {
          "label": "A",
          "text": "None",
          "correct": false
        },
        {
          "label": "B",
          "text": "Patient 1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Patient 2",
          "correct": true
        },
        {
          "label": "D",
          "text": "Patient 3",
          "correct": false
        }
      ],
      "correct_answer": "C. Patient 2",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture3000.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/121_hjniKqX.png"
      ],
      "explanation": "<p><strong>Ans. C)\u00a0Patient 2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Pre-diabetes (also called impaired glucose tolerance) is characterized by blood glucose levels that are higher than normal but not high enough to be classified as diabetes. In an OGTT, pre-diabetes typically shows:</li><li>\u2022 Fasting glucose that may be slightly elevated (100-125 mg/dL) A 2-hour post-load glucose between 140-199 mg/dL</li><li>\u2022 Fasting glucose that may be slightly elevated (100-125 mg/dL)</li><li>\u2022 A 2-hour post-load glucose between 140-199 mg/dL</li><li>\u2022 Analyzing each patient:</li><li>\u2022 Patient 1 (red squares):</li><li>\u2022 Starting glucose ~90 mg/dL (normal fasting) Returns to ~100 mg/dL by 120 min This represents a normal glucose tolerance pattern</li><li>\u2022 Starting glucose ~90 mg/dL (normal fasting)</li><li>\u2022 Returns to ~100 mg/dL by 120 min</li><li>\u2022 This represents a normal glucose tolerance pattern</li><li>\u2022 Patient 2 (blue triangles):</li><li>\u2022 Starting glucose ~80 mg/dL Slow decline but remains elevated at ~145 mg/dL at 120 min This pattern shows impaired glucose tolerance (pre-diabetes) with delayed return to normal</li><li>\u2022 Starting glucose ~80 mg/dL</li><li>\u2022 Slow decline but remains elevated at ~145 mg/dL at 120 min</li><li>\u2022 This pattern shows impaired glucose tolerance (pre-diabetes) with delayed return to normal</li><li>\u2022 Patient 3 (green circles):</li><li>\u2022 Starting glucose ~140 mg/dL (already elevated at fasting) Remains very elevated at 120 min (~210 mg/dL) This pattern is consistent with diabetes mellitus</li><li>\u2022 Starting glucose ~140 mg/dL (already elevated at fasting)</li><li>\u2022 Remains very elevated at 120 min (~210 mg/dL)</li><li>\u2022 This pattern is consistent with diabetes mellitus</li><li>\u2022 Patient 2 best represents pre-diabetes because their fasting level is normal but they show impaired glucose tolerance with the 2-hour value remaining elevated at ~145 mg/d.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The OGTT is used to assess how well the body clears glucose from the bloodstream. In a pre-diabetic state , the 2-hour glucose value is elevated beyond normal but does not reach diabetic levels (140\u2013199 mg/dL). If the value is \u2265200 mg/dL, a diagnosis of diabetes mellitus is made.</li><li>\u27a4 pre-diabetic state</li><li>\u27a4 2-hour glucose value</li><li>\u27a4 diabetes mellitus</li><li>\u27a4 Ref: Harper 30/e p 337 -340.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "407a3d7a",
      "audio": ""
    },
    {
      "text": "A 28-year-old male presents to the clinic with fatigue, muscle cramps, and a recent history of unexplained weight loss. He reports that his symptoms worsen with exercise. His medical history is unremarkable, and he is not on any medications. Laboratory investigations reveal hypoglycemia, especially after periods of fasting or strenuous activity. The physician suspects a metabolic disorder involving glycogen metabolism. Which of the following is NOT involved in the regulation of glycogen phosphorylase, an enzyme pivotal in glycogen breakdown?",
      "options": [
        {
          "label": "A",
          "text": "cAMP",
          "correct": false
        },
        {
          "label": "B",
          "text": "Calmodulin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Protein Kinase A",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glycogenin",
          "correct": true
        }
      ],
      "correct_answer": "D. Glycogenin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Glycogenin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Glycogenin is not involved in the regulation of glycogen phosphorylase .</li><li>\u2022 Glycogenin</li><li>\u2022 glycogen phosphorylase</li><li>\u2022 Glycogenin serves as the core \"primer\" protein upon which glucose units are added to initiate glycogen synthesis , not glycogen breakdown. Once a short glucose chain is built on glycogenin, glycogen synthase and branching enzyme extend the glycogen molecule.</li><li>\u2022 glycogen synthesis</li><li>\u2022 glycogen synthase</li><li>\u2022 branching enzyme</li><li>\u2022 In contrast, glycogen phosphorylase is the rate-limiting enzyme in glycogenolysis (glycogen breakdown), and its regulation is tightly controlled by hormonal and intracellular signaling.</li><li>\u2022 glycogen phosphorylase</li><li>\u2022 glycogenolysis</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A) cAMP: Correct \u2014 cAMP is an important second messenger in the glucagon and epinephrine pathway. It activates Protein Kinase A (PKA) , which phosphorylates phosphorylase kinase , activating it. Phosphorylase kinase then phosphorylates and activates glycogen phosphorylase , enabling glycogen breakdown. Option B) Calmodulin: Correct \u2014 Calmodulin, when bound to calcium, directly activates phosphorylase kinase , bypassing cAMP in tissues such as muscle. This allows muscle cells to match glycogen breakdown to calcium-driven muscle contraction. Option C) Protein Kinase A (PKA): Correct \u2014 PKA is a key regulator of glycogenolysis. Activated by cAMP, it phosphorylates phosphorylase kinase , which then activates glycogen phosphorylase .</li><li>\u2022 Option A) cAMP: Correct \u2014 cAMP is an important second messenger in the glucagon and epinephrine pathway. It activates Protein Kinase A (PKA) , which phosphorylates phosphorylase kinase , activating it. Phosphorylase kinase then phosphorylates and activates glycogen phosphorylase , enabling glycogen breakdown.</li><li>\u2022 Option A) cAMP:</li><li>\u2022 second messenger</li><li>\u2022 Protein Kinase A (PKA)</li><li>\u2022 phosphorylase kinase</li><li>\u2022 glycogen phosphorylase</li><li>\u2022 Option B) Calmodulin: Correct \u2014 Calmodulin, when bound to calcium, directly activates phosphorylase kinase , bypassing cAMP in tissues such as muscle. This allows muscle cells to match glycogen breakdown to calcium-driven muscle contraction.</li><li>\u2022 Option B) Calmodulin:</li><li>\u2022 phosphorylase kinase</li><li>\u2022 glycogen breakdown</li><li>\u2022 Option C) Protein Kinase A (PKA): Correct \u2014 PKA is a key regulator of glycogenolysis. Activated by cAMP, it phosphorylates phosphorylase kinase , which then activates glycogen phosphorylase .</li><li>\u2022 Option C) Protein Kinase A (PKA):</li><li>\u2022 phosphorylase kinase</li><li>\u2022 glycogen phosphorylase</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glycogen phosphorylase is the key enzyme for glycogen breakdown and is activated via phosphorylation pathways involving cAMP , Protein Kinase A , and phosphorylase kinase (which is also activated by calcium-calmodulin in muscle). In contrast, glycogenin functions as the core primer for glycogen synthesis, not degradation, and is not involved in the regulation of glycogen phosphorylase.</li><li>\u27a4 Glycogen phosphorylase</li><li>\u27a4 cAMP</li><li>\u27a4 Protein Kinase A</li><li>\u27a4 phosphorylase kinase</li><li>\u27a4 calcium-calmodulin</li><li>\u27a4 glycogenin</li><li>\u27a4 Ref : Harper 30/e: p180-182</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a8925761",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman, following a meal rich in carbohydrates, undergoes various metabolic adjustments to manage the influx of glucose. One of these adjustments involves the metabolism of glucose-6-phosphate, a key metabolite in glucose homeostasis. Considering the fed state, where glucose is abundant, what is the primary fate of glucose-6-phosphate in tissues?",
      "options": [
        {
          "label": "A",
          "text": "Storage as fructose",
          "correct": false
        },
        {
          "label": "B",
          "text": "Storage as glyceraldehyde-3-phosphate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Enters HMP shunt via ribulose-5-phosphate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Storage as glycogen",
          "correct": true
        }
      ],
      "correct_answer": "D. Storage as glycogen",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Storage as fructose is not a primary pathway for glucose-6-phosphate metabolism in tissues during the fed state.</li><li>\u2022 Option A:</li><li>\u2022 Storage as fructose</li><li>\u2022 not</li><li>\u2022 primary pathway for glucose-6-phosphate metabolism</li><li>\u2022 Option B: Glyceraldehyde-3-phosphate is an intermediate in glycolysis , but the direct storage of glucose-6-phosphate as glyceraldehyde-3-phosphate is not a primary fate in the fed state.</li><li>\u2022 Option B:</li><li>\u2022 Glyceraldehyde-3-phosphate</li><li>\u2022 intermediate in glycolysis</li><li>\u2022 direct storage of glucose-6-phosphate</li><li>\u2022 Option C: While glucose-6-phosphate can enter the Hexose Monophosphate (HMP) shunt , this pathway is primarily active in specific tissues like the liver , and its main function is not for storage but for producing NADPH and ribose-5-phosphate for biosynthetic reactions.</li><li>\u2022 Option C:</li><li>\u2022 glucose-6-phosphate</li><li>\u2022 enter the Hexose Monophosphate</li><li>\u2022 shunt</li><li>\u2022 pathway is primarily active</li><li>\u2022 specific tissues</li><li>\u2022 liver</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The uptake of glucose into the liver GLUT 2 is independent of insulin . In the well fed state \u2192 concentration of glucose entering the liver increases \u2192 increased rate of synthesis of glucose-6-phosphate. This is in excess of the liver\u2019s requirement for energy-yielding metabolism. So, it is used mainly for synthesis of glycogen. In both liver and skeletal muscle, insulin acts to stimulate glycogen synthase and inhibit glycogen phosphorylase</li><li>\u27a4 The uptake of glucose into the liver GLUT 2 is independent of insulin .</li><li>\u27a4 uptake of glucose</li><li>\u27a4 liver GLUT 2</li><li>\u27a4 independent of insulin</li><li>\u27a4 In the well fed state \u2192 concentration of glucose entering the liver increases \u2192 increased rate of synthesis of glucose-6-phosphate.</li><li>\u27a4 This is in excess of the liver\u2019s requirement for energy-yielding metabolism. So, it is used mainly for synthesis of glycogen.</li><li>\u27a4 In both liver and skeletal muscle, insulin acts to stimulate glycogen synthase and inhibit glycogen phosphorylase</li><li>\u27a4 both liver</li><li>\u27a4 skeletal muscle,</li><li>\u27a4 insulin acts</li><li>\u27a4 stimulate glycogen synthase</li><li>\u27a4 inhibit glycogen phosphorylase</li><li>\u27a4 Ref : Harper 30/e: p148.</li><li>\u27a4 Ref</li><li>\u27a4 :</li><li>\u27a4 Harper 30/e: p148.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9f5d7d1a",
      "audio": ""
    },
    {
      "text": "Match the cell organelle with its marker enzymes:",
      "options": [
        {
          "label": "A",
          "text": "1-a, 2-b, 3-c, 4-d",
          "correct": false
        },
        {
          "label": "B",
          "text": "1-a, 2-c, 3-b, 4-d",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-d, 2-a, 3-b, 4-c",
          "correct": true
        },
        {
          "label": "D",
          "text": "1-d, 2-c, 3-a, 4-b",
          "correct": false
        }
      ],
      "correct_answer": "C. 1-d, 2-a, 3-b, 4-c",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/23/untitled-13607.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/screenshot-2024-03-30-171523.png"
      ],
      "explanation": "<p><strong>Ans. C)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Plasma Membrane : The correct marker enzyme is 5\u2019-nucleotidase (d). This enzyme is involved in the hydrolysis of nucleotides to nucleosides and is found in the plasma membrane, playing a role in signal transduction. Golgi Bodies : Galactosyltransferase (a) is the marker enzyme for Golgi bodies . It is involved in the glycosylation of proteins, a process that occurs extensively within the Golgi apparatus. Cytosol : Lactate dehydrogenase (b) is a marker for the cytosol. This enzyme catalyzes the conversion of pyruvate to lactate when oxygen is absent or in short supply, and it is predominantly found in the cytoplasm. Lysosomes : Acid phosphatase (c) is the marker enzyme for lysosomes. It functions in the hydrolysis of phosphate monoesters under acidic conditions, a characteristic activity of the lysosomal digestive process.</li><li>\u2022 Plasma Membrane : The correct marker enzyme is 5\u2019-nucleotidase (d). This enzyme is involved in the hydrolysis of nucleotides to nucleosides and is found in the plasma membrane, playing a role in signal transduction.</li><li>\u2022 Plasma Membrane</li><li>\u2022 5\u2019-nucleotidase</li><li>\u2022 hydrolysis of nucleotides</li><li>\u2022 nucleosides</li><li>\u2022 found in the plasma membrane,</li><li>\u2022 Golgi Bodies : Galactosyltransferase (a) is the marker enzyme for Golgi bodies . It is involved in the glycosylation of proteins, a process that occurs extensively within the Golgi apparatus.</li><li>\u2022 Golgi Bodies</li><li>\u2022 Galactosyltransferase</li><li>\u2022 marker enzyme for Golgi bodies</li><li>\u2022 glycosylation of proteins,</li><li>\u2022 Cytosol : Lactate dehydrogenase (b) is a marker for the cytosol. This enzyme catalyzes the conversion of pyruvate to lactate when oxygen is absent or in short supply, and it is predominantly found in the cytoplasm.</li><li>\u2022 Cytosol</li><li>\u2022 Lactate dehydrogenase</li><li>\u2022 marker for the cytosol.</li><li>\u2022 Lysosomes : Acid phosphatase (c) is the marker enzyme for lysosomes. It functions in the hydrolysis of phosphate monoesters under acidic conditions, a characteristic activity of the lysosomal digestive process.</li><li>\u2022 Lysosomes</li><li>\u2022 Acid phosphatase</li><li>\u2022 marker enzyme for lysosomes.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 12.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 12.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "04966875",
      "audio": ""
    },
    {
      "text": "During a lecture on metabolic pathways, medical students were asked to identify the first committed step in glycolysis and the enzyme that catalyzes it. This step is crucial because it irreversibly commits the substrate to the glycolytic pathway. Which enzyme is responsible for this committed step in glycolysis?",
      "options": [
        {
          "label": "A",
          "text": "Pyruvate dehydrogenase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucokinase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hexokinase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Phosphofructokinase",
          "correct": true
        }
      ],
      "correct_answer": "D. Phosphofructokinase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The first committed step in glycolysis is catalyzed by phosphofructokinase-1 (PFK-1) , which converts:</li><li>\u2022 first committed step</li><li>\u2022 phosphofructokinase-1 (PFK-1)</li><li>\u2022 Fructose-6-phosphate \u2192 Fructose-1,6-bisphosphate</li><li>\u2022 Fructose-6-phosphate \u2192 Fructose-1,6-bisphosphate</li><li>\u2022 This step is considered \"committed\" because, after this conversion, the sugar molecule is no longer available for alternative pathways (such as glycogenesis or the pentose phosphate pathway). It must proceed through glycolysis.</li><li>\u2022 Additionally, this step is irreversible under cellular conditions and is highly regulated \u2014 it represents the rate-limiting step of glycolysis</li><li>\u2022 irreversible</li><li>\u2022 highly regulated</li><li>\u2022 rate-limiting step</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A \u2014 Pyruvate dehydrogenase: Incorrect. This enzyme catalyzes the decarboxylation of pyruvate to acetyl-CoA, which is part of the linking step between glycolysis and the citric acid cycle, not glycolysis itself. Option B \u2014 Glucokinase: Incorrect. Glucokinase catalyzes glucose \u2192 glucose-6-phosphate in the liver and pancreas , and the product can still be shunted into other pathways like glycogenesis or the pentose phosphate pathway. Option C \u2014 Hexokinase: Incorrect. Hexokinase also converts glucose to glucose-6-phosphate in most tissues, but this is not the committed step because glucose-6-phosphate is a central intermediate that can enter multiple pathways beyond glycolysis.</li><li>\u2022 Option A \u2014 Pyruvate dehydrogenase: Incorrect. This enzyme catalyzes the decarboxylation of pyruvate to acetyl-CoA, which is part of the linking step between glycolysis and the citric acid cycle, not glycolysis itself.</li><li>\u2022 Option A \u2014 Pyruvate dehydrogenase:</li><li>\u2022 linking step</li><li>\u2022 Option B \u2014 Glucokinase: Incorrect. Glucokinase catalyzes glucose \u2192 glucose-6-phosphate in the liver and pancreas , and the product can still be shunted into other pathways like glycogenesis or the pentose phosphate pathway.</li><li>\u2022 Option B \u2014 Glucokinase:</li><li>\u2022 glucose \u2192 glucose-6-phosphate</li><li>\u2022 liver and pancreas</li><li>\u2022 Option C \u2014 Hexokinase: Incorrect. Hexokinase also converts glucose to glucose-6-phosphate in most tissues, but this is not the committed step because glucose-6-phosphate is a central intermediate that can enter multiple pathways beyond glycolysis.</li><li>\u2022 Option C \u2014 Hexokinase:</li><li>\u2022 glucose to glucose-6-phosphate</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The first committed step of glycolysis is catalyzed by phosphofructokinase-1 (PFK-1) . It ensures that glucose carbons are committed to energy production via glycolysis. This step is irreversible, highly regulated, and marks a metabolic \"point of no return\" for the glucose molecule.</li><li>\u27a4 first committed step</li><li>\u27a4 phosphofructokinase-1 (PFK-1)</li><li>\u27a4 PFK-1 is a key allosteric enzyme \u2014 activated by AMP and fructose-2,6-bisphosphate and inhibited by ATP and citrate.</li><li>\u27a4 allosteric enzyme</li><li>\u27a4 Ref: Harper 30/e p173</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1bb518f7",
      "audio": ""
    },
    {
      "text": "Acetyl CoA plays a central role in energy metabolism, acting as a substrate for several biosynthetic pathways. Which of the following is NOT a product of Acetyl CoA conversion?",
      "options": [
        {
          "label": "A",
          "text": "Glucose",
          "correct": true
        },
        {
          "label": "B",
          "text": "Fatty acids",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cholesterol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ketone bodies",
          "correct": false
        }
      ],
      "correct_answer": "A. Glucose",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Options B: Fatty acids can be synthesized from acetyl CoA in a process known as lipogenesis, primarily in the liver and adipose tissue.</li><li>\u2022 Options B:</li><li>\u2022 Fatty acids</li><li>\u2022 synthesized from acetyl CoA</li><li>\u2022 lipogenesis,</li><li>\u2022 Options C: Cholesterol is also synthesized from acetyl CoA via the mevalonate pathway , which is critical for cell membrane integrity and as a precursor for steroid hormones.</li><li>\u2022 Options C:</li><li>\u2022 Cholesterol</li><li>\u2022 synthesized from acetyl CoA</li><li>\u2022 mevalonate pathway</li><li>\u2022 Options D: Ketone bodies are produced from acetyl CoA during periods of low carbohydrate availability , such as fasting , prolonged exercise , or low-carbohydrate diets , primarily in the liver.</li><li>\u2022 Options D:</li><li>\u2022 Ketone bodies</li><li>\u2022 produced from acetyl CoA</li><li>\u2022 periods of low carbohydrate availability</li><li>\u2022 fasting</li><li>\u2022 prolonged exercise</li><li>\u2022 low-carbohydrate diets</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acetyl CoA is not a substrate for gluconeogenesis. It is the starting material for Fatty acid and Cholesterol synthesis . It is an intermediate in Ketone body synthesis .</li><li>\u27a4 Acetyl CoA is not a substrate for gluconeogenesis.</li><li>\u27a4 Acetyl CoA</li><li>\u27a4 not</li><li>\u27a4 substrate for gluconeogenesis.</li><li>\u27a4 It is the starting material for Fatty acid and Cholesterol synthesis .</li><li>\u27a4 starting material</li><li>\u27a4 Fatty acid</li><li>\u27a4 Cholesterol synthesis</li><li>\u27a4 It is an intermediate in Ketone body synthesis .</li><li>\u27a4 intermediate in Ketone body synthesis</li><li>\u27a4 Ref : Harper 30/e p188, 189</li><li>\u27a4 Ref :</li><li>\u27a4 Harper 30/e p188, 189</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6e62b342",
      "audio": ""
    }
  ]
}